High Uptake of Postpartum Hormonal Contraception Among HIV-1-Seropositive Women in Kenya
- 1 January 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Sexually Transmitted Diseases
- Vol. 34 (1) , 25-29
- https://doi.org/10.1097/01.olq.0000218880.88179.36
Abstract
Objectives: The objectives of this study were to determine patterns of contraceptive utilization among sexually active HIV-1-seropositive women postpartum and to identify correlates of hormonal contraception uptake. Goal: The goal of this study was to improve delivery of family planning services to HIV-1-infected women in resource-limited settings. Study Design: HIV-1-infected pregnant women were followed prospectively in a perinatal HIV-1 transmission study. Participants were referred to local clinics for contraceptive counseling and management. Results: Among 319 HIV-1-infected women, median time to sexual activity postpartum was 2 months and 231 (72%) women used hormonal contraception for at least 2 months during follow-up, initiating use at approximately 3 months postpartum (range, 1–11 months). Overall, 101 (44%) used DMPA, 71 (31%) oral contraception, and 59 (25%) switched methods during follow-up. Partner notification, infant mortality, and condom use were similar between those using and not using contraception. Conclusions: Using existing the healthcare infrastructure, it is possible to achieve high levels of postpartum hormonal contraceptive utilization among HIV-1-seropositive women.Keywords
This publication has 13 references indexed in Scilit:
- Integrating family planning and prevention of mother-to-child HIV transmission in resource-limited settingsThe Lancet, 2005
- Focus on Women: Linking HIV Care and Treatment with Reproductive Health Services in the MTCT-Plus InitiativeReproductive Health Matters, 2005
- Antenatal Couple Counseling Increases Uptake of Interventions to Prevent HIV-1 TransmissionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2004
- Cost-effectiveness of nevirapine to prevent mother-to-child HIV transmission in eight African countriesAIDS, 2004
- Human Leukocyte Antigen (HLA) B*18 and Protection against Mother-to-Child HIV Type 1 TransmissionAIDS Research and Human Retroviruses, 2004
- Rates, barriers and outcomes of HIV serostatus disclosure among women in developing countries: implications for prevention of mother-to-child transmission programmes.2004
- Salivary Secretory Leukocyte Protease Inhibitor Is Associated with Reduced Transmission of Human Immunodeficiency Virus Type 1 through Breast MilkThe Journal of Infectious Diseases, 2002
- MTCT-Plus Program Has Two Goals: End Maternal HIV Transmission + Treat MothersPublished by American Medical Association (AMA) ,2002
- Sexual and Reproductive Life of Women Informed of Their HIV Seropositivity: A Prospective Cohort Study in Burkina FasoJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Pregnancy and contraception use among urban Rwandan women after HIV testing and counseling.American Journal of Public Health, 1993